QDIS Blog

A blog about chemistry, drug development, science, and technology

March 28, 2007

Replidyne Defines Development Plan for Faropenem

by Ed Vawter @ 6:35 pm.  Filed under Drug Development

Replidyne is continuing to refine its phase III efforts for the antibiotic faropenem.

Replidyne Defines Preliminary Phase III Development Plan for Faropenem: Financial News - Yahoo!
Finance:

This new antibiotic may be the first to be approved under the FDA’s new community standards for antibiotics.

Technorati Tags: ,

Email Ed Vawter



Related Posts:
  • Faropenem Phase III Clinical Trial Stopped to Consider Exclusion of Ketek Comparator
  • Replidyne and Forest End Collaboration on Faropenem
  • Plan B Approved!
  • WHO plan to limit bird flu and contrast to US plan
  • Barr Labs to Resubmit Plan B OTC Application

    • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    Leave a Reply

    [powered by WordPress.]

    QDIS: blogging about chemistry, drug development, science and technology.

    Internal Links

    Categories

    Search This Blog

    Archives

    March 2007
    S M T W T F S
    « Feb   Apr »
     123
    45678910
    11121314151617
    18192021222324
    25262728293031

    Search Entire Site

    Subscribe (It's Free!)

    Performancing

    Chemistry, science, and technology for the future.

    logo2

    General Links

    Blog Links

    Chemistry Journal Feeds

    Chemistry Feeds

    35 queries. 1.211 seconds